Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00193440
Status:
COMPLETED
Last Update Posted:
2010-12-30
First Post:
2005-09-12
Brief Title:
Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkins Lymphoma
Sponsor:
Organization:
SCRI Development Innovations LLC